Role of thymic stromal lymphopoietin (TSLP) in palifermin-mediated immune modulation and protection from acute murine graft-versus-host disease

Journal of Clinical Immunology

Volumn 31, Issue 3, 2011, Pages 406-413

  Ellison, Cynthia A ^a   Lissitsyn, Yuriy V ^a   Packiasamy, Juliet A ^a   Leonard, Warren J ^b   Gartner, John G ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Graft versus host disease; keratinocyte growth factor; palifermin; thymic stromal lymphopoietin

Indexed keywords

PALIFERMIN; THYMIC STROMAL LYMPHOPOIETIN; TRANSCRIPTION FACTOR FOXP3;

ACUTE GRAFT VERSUS HOST DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL LEVEL; CONTROLLED STUDY; CYTOKINE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; GRAFT SURVIVAL; IMMUNOMODULATION; IMMUNOPROPHYLAXIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH2 CELL; WILD TYPE;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; FIBROBLAST GROWTH FACTOR 7; FLOW CYTOMETRY; GENE DELETION; GRAFT VS HOST DISEASE; INJECTIONS, SUBCUTANEOUS; LYMPHOCYTE TRANSFUSION; LYMPHOCYTES; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, KNOCKOUT; TH1-TH2 BALANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 79961172743     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-010-9491-5     Document Type: Article

References (51)

1. JM Woodruff JR Eltringham HW Casey 1969 Early secondary disease in the Rhesus monkey. I. A comparative histopathologic study Lab Invest 20 499 511 4977625 1:STN:280:DyaF1M3gvVSnsQ%3D%3D
2. FP Nestel KS Price TA Seemayer WS Lapp 1992 Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease J Exp Med 175 405 13 1732411 10.1084/jem.175.2.405 1:CAS:528:DyaK38XotF2muw%3D%3D
3. E Stuber A Buschenfeld A von Freier T Arendt UR Folsch 1999 Intestinal crypt cell apoptosis in murine acute graft versus host disease is mediated by tumour necrosis factor alpha and not by the FasL-Fas interaction: effect of pentoxifylline on the development of mucosal atrophy Gut 45 229 35 10403735 10.1136/gut.45.2.229 1:CAS:528:DyaK1MXltleiur4%3D (Pubitemid 29333772)
4. P Garside AK Hutton A Severn FY Liew AM Mowat 1992 Nitric oxide mediates intestinal pathology in graft-vs.-host disease Eur J Immunol 22 2141 5 1639108 10.1002/eji.1830220827 1:CAS:528:DyaK38XlsV2it7o%3D
5. PW Finch JS Rubin T Miki D Ron SA Aaronson 1989 Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth Science 245 752 5 2475908 10.1126/science.2475908 1:CAS:528:DyaK3cXhslaqtLs%3D (Pubitemid 19214010)
6. JS Rubin H Osada PW Finch WG Taylor S Rudikoff SA Aaronson 1989 Purification and characterization of a newly identified growth factor specific for epithelial cells Proc Natl Acad Sci USA 86 802 6 2915979 10.1073/pnas.86.3.802 1:CAS:528:DyaL1MXhtVygt7k%3D (Pubitemid 19056244)
7. R Boismenu WL Havran 1994 Modulation of epithelial cell growth by intraepithelial gamma delta T cells Science 266 1253 5 7973709 10.1126/science.7973709 1:CAS:528:DyaK2MXit1Grtb0%3D (Pubitemid 24371285)
8. ES Yi AS Shabaik DL Lacey AA Bedoya S Yin RM Housley DM Danilenko W Benson AM Cohen GF Pierce, et al. 1995 Keratinocyte growth factor causes proliferation of urothelium in vivo J Urol 154 1566 70 7658592 10.1016/S0022-5347(01)66930-1 1:STN:280:DyaK2MzoslGhug%3D%3D
9. L Staiano-Coico JG Krueger JS Rubin S D'Limi VP Vallat L Valentino T Fahey 3rd A Hawes G Kingston MR Madden, et al. 1993 Human keratinocyte growth factor effects in a porcine model of epidermal wound healing J Exp Med 178 865 78 8350059 10.1084/jem.178.3.865 1:CAS:528:DyaK3sXltlWqtb4%3D (Pubitemid 23260424)
10. DP Bottaro JS Rubin D Ron PW Finch C Florio SA Aaronson 1990 Characterization of the receptor for keratinocyte growth factor. Evidence for multiple fibroblast growth factor receptors J Biol Chem 265 12767 70 2165484 1:CAS:528:DyaK3cXkvFajs78%3D
11. RM Housley CF Morris W Boyle B Ring R Biltz JE Tarpley SL Aukerman PL Devine RH Whitehead GF Pierce 1994 Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract J Clin Invest 94 1764 77 7962522 10.1172/JCI117524 1:CAS:528:DyaK2cXmvFelurY%3D (Pubitemid 24348211)
12. TR Ulich ES Yi R Cardiff S Yin N Bikhazi R Biltz CF Morris GF Pierce 1994 Keratinocyte growth factor is a growth factor for mammary epithelium in vivo. The mammary epithelium of lactating rats is resistant to the proliferative action of keratinocyte growth factor Am J Pathol 144 862 8 8178937 1:CAS:528:DyaK2cXltVSltbs%3D (Pubitemid 24160626)
13. JA Parrott G Kim R Mosher MK Skinner 2000 Expression and action of keratinocyte growth factor (KGF) in normal ovarian surface epithelium and ovarian cancer Mol Cell Endocrinol 167 77 87 11000522 10.1016/S0303-7207(00) 00284-7 1:CAS:528:DC%2BD3cXms1Srurw%3D
14. GF Pierce D Yanagihara K Klopchin DM Danilenko E Hsu WC Kenney CF Morris 1994 Stimulation of all epithelial elements during skin regeneration by keratinocyte growth factor J Exp Med 179 831 40 7509362 10.1084/jem.179.3.831 1:CAS:528:DyaK2cXhsFCqsLo%3D (Pubitemid 24065640)
15. RJ Panos JS Rubin KG Csaky SA Aaronson RJ Mason 1993 Keratinocyte growth factor and hepatocyte growth factor/scatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast-conditioned medium J Clin Invest 92 969 77 7688769 10.1172/JCI116673 1:STN:280:DyaK3szlt1yntQ%3D%3D (Pubitemid 23262421)
16. ES Yi ST Williams H Lee DM Malicki EM Chin S Yin J Tarpley TR Ulich 1996 Keratinocyte growth factor ameliorates radiation- and bleomycin-induced lung injury and mortality Am J Pathol 149 1963 70 8952531 1:CAS:528: DyaK2sXjtFOmtQ%3D%3D (Pubitemid 26415215)
17. TR Ulich L Whitcomb W Tang P O'Conner Tressel J Tarpley ES Yi D Lacey 1997 Keratinocyte growth factor ameliorates cyclophosphamide-induced ulcerative hemorrhagic cystitis Cancer Res 57 472 5 9012476 1:CAS:528:DyaK2sXhtVKgur8%3D (Pubitemid 27081666)
18. CL Farrell JV Bready KL Rex JN Chen CR DiPalma KL Whitcomb S Yin DC Hill B Wiemann CO Starnes AM Havill ZN Lu SL Aukerman GF Pierce A Thomason CS Potten TR Ulich DL Lacey 1998 Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality Cancer Res 58 933 9 9500453 1:CAS:528:DyaK1cXhsFersrY%3D (Pubitemid 28182461)
19. S Frank B Munz S Werner 1997 The human homologue of a bovine non-selenium glutathione peroxidase is a novel keratinocyte growth factor-regulated gene Oncogene 14 915 21 9050990 10.1038/sj.onc.1200905 1:CAS:528:DyaK2sXhvFSmtb0%3D (Pubitemid 27122423)
20. M Takeoka WF Ward H Pollack DW Kamp RJ Panos 1997 KGF facilitates repair of radiation-induced DNA damage in alveolar epithelial cells Am J Physiol 272 L1174 80 9227520 1:CAS:528:DyaK2sXktlKntb8%3D
21. IM Lombaert JF Brunsting PK Wierenga HH Kampinga G de Haan RP Coppes 2008 Keratinocyte growth factor prevents radiation damage to salivary glands by expansion of the stem/progenitor pool Stem Cells 26 2595 601 18669914 10.1634/stemcells.2007-1034 1:CAS:528:DC%2BD1cXhtlyku7vM
22. A Panoskaltsis-Mortari DL Lacey DA Vallera BR Blazar 1998 Keratinocyte growth factor administered before conditioning ameliorates graft-versus-host disease after allogeneic bone marrow transplantation in mice Blood 92 3960 7 9808590 1:CAS:528:DyaK1cXnsVKltLk%3D (Pubitemid 28525223)
23. OI Krijanovski GR Hill KR Cooke T Teshima JM Crawford YS Brinson JL Ferrara 1999 Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease Blood 94 825 31 10397751 1:CAS:528: DyaK1MXksVemu7k%3D (Pubitemid 29323898)
24. CA Ellison SA Natuik JM Fischer AR McIntosh SA Scully EJ Bow DM Danilenko KT Hayglass JG Gartner 2004 Effect of recombinant human keratinocyte growth factor (rHuKGF) on the immunopathogenesis of intestinal graft-vs.-host disease induced without a preconditioning regimen J Clin Immunol 24 197 211 15024187 10.1023/B:JOCI.0000019785.35850.a5 1:CAS:528:DC%2BD2cXitV2ku7s%3D (Pubitemid 38457234)
25. A Panoskaltsis-Mortari PA Taylor JS Rubin A Uren LA Welniak WJ Murphy CL Farrell DL Lacey BR Blazar 2000 Keratinocyte growth factor facilitates alloengraftment and ameliorates graft-versus-host disease in mice by a mechanism independent of repair of conditioning-induced tissue injury Blood 96 4350 6 11110712 1:CAS:528:DC%2BD3cXosl2htb4%3D
26. S Rossi BR Blazar CL Farrell DM Danilenko DL Lacey KI Weinberg W Krenger GA Hollander 2002 Keratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host disease Blood 100 682 91 12091365 10.1182/blood.V100.2.682 1:CAS:528:DC%2BD38XlsVWgtbk%3D (Pubitemid 34761136)
27. D Min PA Taylor A Panoskaltsis-Mortari B Chung DM Danilenko C Farrell DL Lacey BR Blazar KI Weinberg 2002 Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation Blood 99 4592 600 12036893 10.1182/blood.V99.12.4592 1:CAS:528:DC%2BD38XksFGksLc%3D (Pubitemid 34627232)
28. O Alpdogan VM Hubbard OM Smith N Patel S Lu GL Goldberg DH Gray J Feinman AA Kochman JM Eng D Suh SJ Muriglan RL Boyd MR van den Brink 2006 Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration Blood 107 2453 60 16304055 10.1182/blood-2005-07-2831 1:CAS:528:DC%2BD28XisFOjuro%3D (Pubitemid 43345567)
29. D Min A Panoskaltsis-Mortari OM Kuro GA Hollander BR Blazar KI Weinberg 2007 Sustained thymopoiesis and improvement in functional immunity induced by exogenous KGF administration in murine models of aging Blood 109 2529 37 17138819 10.1182/blood-2006-08-043794 1:CAS:528:DC%2BD2sXnslygsbo%3D (Pubitemid 46425898)
30. CA Ellison BM Makar JM Wiseman I Gheorghiu M Taniguchi JG Gartner 2008 Palifermin mediates immunoregulatory effects in addition to its cytoprotective effects in mice with acute graft-versus-host disease J Clin Immunol 28 600 15 18592360 10.1007/s10875-008-9216-1 1:CAS:528:DC%2BD1cXhtVyjt7jN
31. M Erickson S Morkowski S Lehar G Gillard C Beers J Dooley JS Rubin A Rudensky AG Farr 2002 Regulation of thymic epithelium by keratinocyte growth factor Blood 100 3269 78 12384427 10.1182/blood-2002-04-1036 1:CAS:528:DC%2BD38XosVSisbY%3D (Pubitemid 35217077)
32. PA Reche V Soumelis DM Gorman T Clifford M Liu M Travis SM Zurawski J Johnston YJ Liu H Spits R de Waal Malefyt RA Kastelein JF Bazan 2001 Human thymic stromal lymphopoietin preferentially stimulates myeloid cells J Immunol 167 336 43 11418668 1:CAS:528:DC%2BD3MXkslSqu7Y%3D (Pubitemid 32567797)
33. A Pandey K Ozaki H Baumann SD Levin A Puel AG Farr SF Ziegler WJ Leonard HF Lodish 2000 Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin Nat Immunol 1 59 64 10881176 1:CAS:528: DC%2BD3cXls1yqs7o%3D
34. LS Park U Martin K Garka B Gliniak JP Di Santo W Muller DA Largaespada NG Copeland NA Jenkins AG Farr SF Ziegler PJ Morrissey R Paxton JE Sims 2000 Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: formation of a functional heteromeric complex requires interleukin 7 receptor J Exp Med 192 659 70 10974032 10.1084/jem.192.5.659 1:CAS:528:DC%2BD3cXmtlegsbk%3D
35. SL Friend S Hosier A Nelson D Foxworthe DE Williams A Farr 1994 A thymic stromal cell line supports in vitro development of surface IgM+ B cells and produces a novel growth factor affecting B and T lineage cells Exp Hematol 22 321 8 8112430 1:CAS:528:DyaK2cXjt1Wjurw%3D (Pubitemid 24094344)
36. M Omori S Ziegler 2007 Induction of IL-4 expression in CD4(+) T cells by thymic stromal lymphopoietin J Immunol 178 1396 404 17237387 1:CAS:528:DC%2BD2sXntVGhtw%3D%3D (Pubitemid 46154610)
37. L Shi SW Leu F Xu X Zhou H Yin L Cai L Zhang 2008 Local blockade of TSLP receptor alleviated allergic disease by regulating airway dendritic cells Clin Immunol 129 202 10 18757241 10.1016/j.clim.2008.07.015 1:CAS:528: DC%2BD1cXht1Kgt7zI
38. HK Jessup AW Brewer M Omori EA Rickel AL Budelsky BR Yoon SF Ziegler MR Comeau 2008 Intradermal administration of thymic stromal lymphopoietin induces a T cell- and eosinophil-dependent systemic Th2 inflammatory response J Immunol 181 4311 9 18768889 1:CAS:528:DC%2BD1cXhtVKntbnO
39. Y Nakamura M Miyata T Ohba T Ando K Hatsushika F Suenaga N Shimokawa Y Ohnuma R Katoh H Ogawa A Nakao 2008 Cigarette smoke extract induces thymic stromal lymphopoietin expression, leading to T(H)2-type immune responses and airway inflammation J Allergy Clin Immunol 122 1208 14 18926564 10.1016/j.jaci.2008.09.022 1:CAS:528:DC%2BD1cXhsV2ltrzM
40. B Zhou MB Headley T Aye J Tocker MR Comeau SF Ziegler 2008 Reversal of thymic stromal lymphopoietin-induced airway inflammation through inhibition of Th2 responses J Immunol 181 6557 62 18941246 1:CAS:528:DC%2BD1cXht1Krt77K
41. A Al-Shami R Spolski J Kelly T Fry PL Schwartzberg A Pandey CL Mackall WJ Leonard 2004 A role for thymic stromal lymphopoietin in CD4(+) T cell development J Exp Med 200 159 68 15263024 10.1084/jem.20031975 1:CAS:528:DC%2BD2cXmtFSqsrY%3D (Pubitemid 38982175)
42. JG Gartner AC Merry CI Smith 1988 An analysis of pulmonary natural killer cell activity in F1-hybrid mice with acute graft-versus-host reactions Transplantation 46 879 86 3206532 10.1097/00007890-198812000-00018 1:STN:280:DyaL1M%2FosFSktw%3D%3D (Pubitemid 19013236)
43. CA Ellison JM Fischer KT HayGlass JG Gartner 1998 Murine graft-versus-host disease in an F1-hybrid model using IFN-gamma gene knockout donors J Immunol 161 631 40 9670937 1:CAS:528:DyaK1cXksFGkt74%3D (Pubitemid 28323524)
44. M Bruinsma PL van Soest PJ Leenen BN Lambrecht T Cupedo B Lowenberg JJ Cornelissen E Braakman 2007 Keratinocyte growth factor induces expansion of murine peripheral CD4+Foxp3+ regulatory T cells and increases their thymic output J Immunol 179 7424 30 18025186 1:CAS:528:DC%2BD2sXhtlajt7zL
45. Y Miura CJ Thoburn EC Bright ML Phelps T Shin EC Matsui WH Matsui S Arai EJ Fuchs GB Vogelsang RJ Jones AD Hess 2004 Association of Foxp3 regulatory gene expression with graft-versus-host disease Blood 104 2187 93 15172973 10.1182/blood-2004-03-1040 1:CAS:528:DC%2BD2cXotVyjsr4%3D (Pubitemid 39297878)
46. E Zorn HT Kim SJ Lee BH Floyd D Litsa S Arumugarajah R Bellucci EP Alyea JH Antin RJ Soiffer J Ritz 2005 Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease Blood 106 2903 11 15972448 10.1182/blood-2005-03-1257 1:CAS:528:DC%2BD2MXhtFantbfK (Pubitemid 41510772)
47. PA Taylor CJ Lees BR Blazar 2002 The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality Blood 99 3493 9 11986199 10.1182/blood.V99.10.3493 1:CAS:528:DC%2BD38XjvVGnsrs%3D (Pubitemid 34534513)
48. JL Cohen A Trenado D Vasey D Klatzmann BL Salomon 2002 CD4(+)CD25(+) immunoregulatory T cells: new therapeutics for graft-versus-host disease J Exp Med 196 401 6 12163568 10.1084/jem.20020090 1:CAS:528:DC%2BD38XmtVOhtLc%3D (Pubitemid 34875668)
49. PA Taylor A Panoskaltsis-Mortari JM Swedin PJ Lucas RE Gress BL Levine CH June JS Serody BR Blazar 2004 L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection Blood 104 3804 12 15292057 10.1182/blood-2004-05-1850 1:CAS:528:DC%2BD2cXhtVGltb3F (Pubitemid 39564461)
50. P Hoffmann J Ermann M Edinger CG Fathman S Strober 2002 Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation J Exp Med 196 389 99 12163567 10.1084/jem.20020399 1:CAS:528:DC%2BD38XmtVOhtLY%3D (Pubitemid 34875667)
51. CA Ellison SA Natuik AR McIntosh SA Scully DM Danilenko JG Gartner 2003 The role of interferon-gamma, nitric oxide and lipopolysaccharide in intestinal graft-versus-host disease developing in F1-hybrid mice Immunology 109 440 9 12807491 10.1046/j.1365-2567.2003.01663.x 1:CAS:528:DC%2BD3sXltlCjt78%3D (Pubitemid 36783271)